Format

Send to

Choose Destination
J Am Heart Assoc. 2019 May 21;8(10):e011306. doi: 10.1161/JAHA.118.011306.

New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017.

Author information

1
1 European Medicines Agency London United Kingdom.
2
2 Food and Drug Administration Silver Spring MD.
3
3 Pediatric Cardiology Unit Centre Universitaire de Cardiologie et Chirurgie Cardiaque Pédiatrique University Hospitals of Geneva City of Geneva Switzerland.
4
4 Center for Congenital Heart Diseases Department of Pediatric Cardiology Beatrix Children's Hospital University Medical Center Groningen University of Groningen the Netherlands.
5
5 Bayer AG, Pharmaceuticals, Research and Development Wuppertal Germany.
6
6 PH Sweden Göteborg Sweden.
7
7 Heart Institute Children's Hospital Colorado University of Colorado School of Medicine Aurora CO.
8
8 Perelman School of Medicine University of Pennsylvania Philadelphia PA.
9
9 Health Canada Ottawa Ontario Canada.
10
10 Actelion Pharmaceuticals Ltd Allscwil Switzerland.
11
11 Childrens Memorial Health Institute Warsaw Poland.
12
12 Department of Paediatric Cardiology Paediatric Heart Center Lund University and Skåne University Hospital Lund Sweden.
13
13 MSD Lucerne Switzerland.
14
14 Medicines Evaluation Board Utrecht the Netherlands.

KEYWORDS:

patient‐reported outcome; pediatrics; pharmacology; research ethics; research method

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center